Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins.

Publications show all

Molecular Partners has published 10 articles.

Patents show all

65Applications25Issued

Clinical Trials show all

3Phase 12Phase 1/Phase 2